Mohn Cancer Research Laboratory

Findings regarding new origin of breast cancer presented at ASCO 2022

In an interview with journalist Julie Kalveland from Dagens Medisin (04.06.2022) Professor Per Eystein Lønning shares the most important findings from a Norwegian-American collaboration study on BRCA1-methylation in breast and ovarian cancer. These findings were presented orally by Lønning at ASCO (03.06.2022).

The picture shows Professor Per Eystein Lønning being interviewed at ASCO
Screenshot from Dagens Medisin_04.06.2022

Main content

See the full interview and read more on the webpages of Dagens Medisin (Only in Norwegian).